A Study Evaluating the Safety and Efficacy of Atezolizumab in Combination With Obinutuzumab Plus Lenalidomide in Patients With Relapsed or Refractory Follicular Lymphoma
Cancer Non Hodgkin Lymphoma (NHL) Follicular Lymphoma Lymphoma
For the latest version of this information please go to www.forpatients.roche.com